MRI(magnetic resonance imaging)-based fibroids procedure before FDA committee
This article was originally published in Clinica
Executive Summary
An FDA advisory committee will meet on June 3 to consider Insightec's premarket approval application for its minimally invasive method for controlling uterine fibroids. The company's technique uses magnetic resonance imaging to guide focused ultrasound ablation therapy.